Cargando…
NADPH oxidase 2 activity in Parkinson’s disease
Mitochondrial dysfunction and oxidative stress are strongly implicated in Parkinson’s disease (PD) pathogenesis and there is evidence that mitochondrially-generated superoxide can activate NADPH oxidase 2 (NOX2). Although NOX2 has been examined in the context of PD, most attention has focused on gli...
Autores principales: | Keeney, Matthew T., Hoffman, Eric K., Farmer, Kyle, Bodle, Christopher R., Fazzari, Marco, Zharikov, Alevtina, Castro, Sandra L., Hu, Xiaoping, Mortimer, Amanda, Kofler, Julia K., Cifuentes-Pagano, Eugenia, Pagano, Patrick J., Burton, Edward A., Hastings, Teresa G., Greenamyre, J. Timothy, Di Maio, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284948/ https://www.ncbi.nlm.nih.gov/pubmed/35577065 http://dx.doi.org/10.1016/j.nbd.2022.105754 |
Ejemplares similares
-
Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease
por: Di Maio, Roberto, et al.
Publicado: (2023) -
Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy
por: Van Laar, Amber D., et al.
Publicado: (2023) -
NADPH oxidases in Parkinson’s disease: a systematic review
por: Belarbi, Karim, et al.
Publicado: (2017) -
LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson’s disease
por: Rocha, Emily M., et al.
Publicado: (2019) -
MicroRNAs in the Regulation of NADPH Oxidases in Vascular Diabetic and Ischemic Pathologies: A Case for Alternate Inhibitory Strategies?
por: Wallace, Sean R., et al.
Publicado: (2022)